Neuromodulation Devices market worldwide was worth $4.5 billion US dollars. AMR Group projects that the market will reach US$ 8.9 billion by 2031, growing at a CAGR of 10.2 percent between 2022 and 2031.
Neuromodulation devices are medical devices that are used to treat various neurological disorders by delivering electrical or chemical signals to specific areas of the nervous system. These devices work by altering the electrical activity of nerve cells, which can help to alleviate pain, improve motor function, and reduce the symptoms of various neurological disorders.
There are several different types of neuromodulation devices, including: Spinal cord stimulators: These devices are implanted under the skin and use electrical signals to block pain signals from reaching the brain. They are used to treat chronic pain conditions, such as back pain and neuropathic pain. Deep brain stimulators: These devices are implanted in the brain and use electrical signals to treat movement disorders, such as Parkinson’s disease and essential tremor.
Get a Free Sample Copy of a Research Report: https://analyticsmarketresearch.com/sample-request/neuromodulation-devices-market/36014/
Market Segmentation
The neuromodulation devices market can be segmented based on the type of device, application, and end-user:
By Type of Device:
Implantable Devices: This segment includes spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, and vagus nerve stimulators, among others.
External Devices: This segment includes transcranial magnetic stimulators, transcranial direct current stimulators, and transcutaneous electrical nerve stimulators, among others.
By Application:
Chronic Pain: This segment includes neuropathic pain, failed back surgery syndrome, complex regional pain syndrome, and chronic migraine, among others.
Movement Disorders: This segment includes Parkinson’s disease, essential tremors, and dystonia, among others.
Epilepsy: This segment includes focal and generalized epilepsy.
Others: This segment includes urinary and fecal incontinence, gastroparesis, and depression, among others.
By End-User:
Hospitals: Hospitals are the major end-users of neuromodulation devices, where these devices are used for the treatment of chronic pain and neurological disorders.
Key Players:
The neuromodulation devices market is highly competitive with several players operating in the market. Some of the major companies in the market include:
Medtronic: Medtronic is a leading player in the neuromodulation devices market with a wide range of products, including spinal cord stimulators, deep brain stimulators, and sacral nerve stimulators.
Abbott: Abbott is a major player in the neuromodulation devices market, with a focus on neurostimulation devices for chronic pain management, including spinal cord stimulators and dorsal root ganglion stimulators.
Boston Scientific: Boston Scientific is a leading player in the neuromodulation devices market, with a range of products, including spinal cord stimulators, deep brain stimulators, and peripheral nerve stimulators.
LivaNova: LivaNova is a major player in the neuromodulation devices market, with a focus on vagus nerve stimulation for the treatment of epilepsy and depression.
Nevro: Nevro is a fast-growing player in the neuromodulation devices market, with a focus on high-frequency spinal cord stimulation for the treatment of chronic pain.
Other players in the market include Stimwave, Synapse Biomedical, NeuroMetrix, Nuvectra, and ElectroCore. The competitive landscape of the neuromodulation devices market is driven by factors such as product innovation, pricing strategies, regulatory approvals, and marketing and distribution strategies. With the increasing demand for neuromodulation devices, competition among the players is expected to intensify in the coming years.
Regional Analysis
The neuromodulation devices market varies by region due to differences in healthcare infrastructure, prevalence of neurological disorders, and regulatory environment. North America: North America is the largest market for neuromodulation devices, with the United States accounting for the majority of the market share. The region’s market growth is driven by factors such as the high prevalence of neurological disorders, favorable reimbursement policies, and increasing investment in research and development.
Europe: Europe is the second-largest market for neuromodulation devices, with countries such as Germany, the UK, and France being the major contributors. The market growth is driven by factors such as the aging population, increasing prevalence of chronic pain and neurological disorders, and the presence of well-established healthcare infrastructure.
Asia-Pacific: The Asia-Pacific region is expected to see the fastest growth in the neuromodulation devices market due to the increasing prevalence of neurological disorders, increasing healthcare expenditure, and growing awareness of neuromodulation treatments. China, Japan, and India are the major contributors to the market in the region.
Latin America: The neuromodulation devices market in Latin America is expected to grow steadily due to factors such as increasing healthcare expenditure and the growing prevalence of neurological disorders. Brazil and Mexico are the major contributors to the market in the region.
Middle East and Africa: The neuromodulation devices market in the Middle East and Africa is expected to grow slowly due to factors such as the limited availability of neuromodulation devices, low healthcare expenditure, and limited awareness and acceptance of these devices among healthcare providers and patients. Overall, the neuromodulation devices market is expected to grow globally due to the increasing prevalence of neurological disorders and the development of new and more advanced devices. However, the growth rate and market size vary by region due to differences in healthcare infrastructure, prevalence of neurological disorders, and regulatory environment.
Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.
Get the Detail Information: https://analyticsmarketresearch.com/reports/neuromodulation-devices-market/36014/
About US:
Analytics Market Research is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.
Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. Analytics Market Research is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.
Contact US:
Analytics Market Research
99 WALL STREET, #2124 NEW YORK, NY 10005
Phone: +1(650)-666-4592
Email: [email protected]
Web: https://analyticsmarketresearch.com/
